Quality of life experiences of breast cancer patients undergoing chemotherapy: a descriptive qualitative study from Ayder Comprehensive Specialized Hospital, Ethiopia Authors: Desta Hailu Aregawi, Haftu Berhe Gebru, Hailemariam Berhe Kahsay, Kalayu Kidanu Berhe, Yibrah Berhe, Senait Abrha, Gerezgiher Buruh Abera Published: 2026 ABSTRACT AbstractHealth-related quality of life (HRQoL) is a key aspect of breast cancer care, encompassing patients’ physical, emotional, and social well-being. Although survival rates have improved, chemotherapy’s adverse effects continue to compromise quality of life. In Ethiopia, particularly in Tigray, limited data exist on HRQoL among breast cancer patients. This study explored the HRQoL of women undergoing chemotherapy at Ayder Comprehensive Specialized Hospital. A descriptive qualitative study was conducted from February to March 2020 among women receiving chemotherapy for at least six months. Data were collected through semi-structured, in-depth interviews with eighteen purposively selected participants until data saturation was reached. Interviews were conducted in Tigrigna, transcribed verbatim, translated into English, and reviewed for accuracy. Thematic content analysis using Open Code software identified key themes through collaborative coding and consensus. The study found significant physical limitations, with participants unable to engage in strenuous activities or walk long distances. Emotional well-being was deeply affected, with many expressing fear and distress about their prognosis. However, emotional stability improved with counseling and healthcare support. Social isolation was common, exacerbated by the financial burden of treatment. Participants also reported common chemotherapy side effects, including hair loss, fatigue, menstrual disturbances, and loss of appetite. Breast cancer patients in Tigray experience substantial declines in HRQoL due to treatment side effects, emotional strain, and financial hardship. Strengthening psychosocial support, counseling, and financial aid is vital to enhance coping, reduce anxiety, and improve overall quality of life.Keywords: Breast cancer, Qualitative, Symptom experience, Emotional wellbeing, Treatment impactSubject terms: Cancer, Health care, Oncology, Psychology, Psychology Introduction Health-related quality of life (HRQOL) is defined as the subjective perception of how a disease and its treatment impact a patient’s health status1. It reflects an individual’s view of their position in life, considering the culture and value systems in which they live, and in relation to their goals, expectations, standards, and concerns. This definition acknowledges that quality of life is a subjective concept, shaped by an individual’s personal judgment2. Over the past decade, quality of life (QOL) has become a key outcome measure in the treatment of cancer patients. It is a multidimensional construct that encompasses perceptions of both the positive and negative aspects of physical, emotional, social, and cognitive functions. Additionally, it includes the negative effects of somatic discomfort and other symptoms caused by the disease or its treatment3.It is considered as one of the main determinants of treatment success in modern oncology4,5. Quality of life has become a widely accepted measure of outcome in the management of cancer patients, playing a key role in their overall care3,6,7. This is in part due to the rising number of breast cancer cases. Cancer is a major global public health concern. The International Agency for Research on Cancer (IARC) estimates that about one in five individuals will develop cancer in their lifetime, reflecting a rising global burden8–10. In 2022, there were approximately 20 million new cases and 9.7 million deaths worldwide, with breast cancer being the most commonly diagnosed cancer in women, accounting for about 11.6% of all cases8–10. In Ethiopia, cancer is an increasing health challenge, with an estimated 60,000–77,000 new cases and 39,000–44,000 deaths annually10,11. Breast cancer is the leading cancer among women, representing about 30–33% of cases and a major cause of cancer-related mortality8,10,11. The World Health Organization notes that cancer is a leading global cause of death, with a growing burden in low- and middle-income countries such as Ethiopia10. Late presentation, limited diagnostic access, and delayed treatment contribute to high mortality, with breast cancer remaining the dominant contributor among women. On the other hand, advancements in the early detection and treatment of breast cancer have resulted in longer survival rates for these patients. Moreover, breast cancer can significantly impact women’s sense of identity, making it crucial to study the quality of life in women who undergo breast removal. Additionally, women often play a central role within their families, and when a woman is diagnosed with breast cancer, it can affect the well-being of all family members5. The period around diagnosis, the initial stages of adjuvant treatment, and the months immediately following the completion of adjuvant therapy are times of poor adjustment and reduced quality of life for breast cancer patients12,13. Research has indicated that a decline in health-related quality of life due to chemotherapy side effects can predict early discontinuation of treatment in these patients14. Conversely, studies on the post-treatment adjustment of breast cancer survivors suggest that these patients may benefit from an improved quality of life15. However, according to other findings, the end of treatment can be exceedingly stressful for women with breast cancer, especially for those who have received adjuvant chemotherapy and/or radiation treatments16. Being diagnosed with breast cancer is an incredibly stressful experience that has profound consequences for most individuals, impacting all areas of life. The temporary side effects of treatment can also affect a patient’s health-related quality of life during the treatment process. Typically, the initial treatment for breast cancer involves surgery, after which many patients are advised to undergo additional treatments such as radiotherapy, chemotherapy, or hormonal therapy. These various factors can all contribute to a decline in the patient’s quality of life17–19. Furthermore, the incurable nature of breast cancer and the possibility of its recurrence often causes more psychological distress than the diagnosis of primary breast cancer itself, further impacting the patients’ quality of life20,21. However, a more recent study found that socio-demographic factors such as education level, marital status, age, comorbidities (e.g., diabetes, high cholesterol), and the type of treatment (surgery, radiotherapy, or hormone therapy) do not significantly affect the quality of life22. Assessing the quality of life of patients provides numerous benefits, including helping clinicians and patients set accurate expectations about the likely impact of treatments on well-being and functioning. It also enables the identification of common issues that need to be addressed, as well as the recognition of effective therapies and interventions for managing these problems. Furthermore, research suggests that quality of life data can enhance clinicians’ ability to predict treatment responses and survival times in certain contexts. Additionally, numerous studies have shown that a better quality of life is linked to longer survival in patients with various types of cancer23–25. However, to the best of the researchers’ knowledge, no quantitative studies have been conducted in Ethiopia to assess the quality of life of breast cancer patients. Given the rising burden of breast cancer, its impact on quality of life, and the limited local evidence, the objective of this study is to assess the quality of life among breast cancer patients undergoing chemotherapy. Methods and materials Study area The study was conducted at Ayder Comprehensive Specialized Hospital (ACSH) in Mekelle City, Tigray, 783 km north of Addis Ababa. Serving 8 million people across Tigray, Afar, and Amhara, ACSH is the second-largest hospital in Ethiopia with about 500 inpatient beds. It functions as a teaching hospital for Mekelle University’s College of Health Sciences. The oncology department has 10 doctors, 108 beds, and an outpatient oncology clinic. ACSH began offering referral and specialized services in 2000 E.C.(26). Study design and period A descriptive qualitative study was conducted at Ayder Comprehensive Specialized Hospital to explore chemotherapy patients’ quality of life from their own perspectives. The study was entirely qualitative in nature, aiming to obtain detailed descriptions and personal experiences rather than numerical or statistical findings. Data collection was conducted from February to March 2020. Study population The study population consisted of breast cancer patients who had been receiving chemotherapy for at least six months prior to the data collection period. Sample size determination The study determined the sample size based on information saturation, ensuring comprehensive data collection without redundancy. Eighteen in-depth interviews were conducted with chemotherapy patients, purposely selected to reflect diverse experiences. The selection criteria aligned with the research objectives, ensuring varied perspectives on quality of life. Interviews continued until no new themes or insights emerged. This approach ensured sufficient data was collected to capture a full range of experiences. Participant selection and sampling procedure Participants were purposively selected to ensure a diverse representation of breast cancer patients receiving chemotherapy, considering factors like reproductive history and residential background. The study included patients who had been undergoing chemotherapy for at least six months and could actively engage in interviews. The Principal Investigator (PI) was responsible for selecting individuals with the most relevant and insightful experiences. Oncology nurses at Ayder Comprehensive Specialized Hospital helped identify and contact eligible participants, considering their health status and ability to participate. Women who were too ill to communicate effectively were excluded from the study. The selection process aimed to capture a wide range of experiences to provide a comprehensive understanding of chemotherapy’s impact on quality of life. This approach ensured the inclusion of participants who could share meaningful insights. The sample reflected diverse patient backgrounds to enrich the data. By excluding those unable to participate, the study maintained quality in the information gathered. Overall, the procedure aimed for a well-rounded and informative sample to explore the experiences of breast cancer patients undergoing chemotherapy. Data collection tools and procedures Data were collected through in-depth interviews with breast cancer patients undergoing chemotherapy using semi-structured, open-ended, and non-directive questions. The interviews were guided by domains derived from the EORTC QLQ-C30, which assesses physical, emotional, cognitive, and social functioning, as well as symptoms such as fatigue, pain, and nausea. Although the EORTC QLQ-C30 was originally developed as a quantitative instrument for measuring health-related quality of life (HRQOL) in cancer patients, it was not applied as a quantitative measurement tool in this study. Instead, its domains were adapted to the study context and used as a sensitizing conceptual framework to inform the development of interview questions and guide the organization of the thematic analysis. This approach enabled an in-depth exploration of participants’ experiences and perceptions of HRQOL during chemotherapy treatment. The interviews were conducted in a comfortable and quiet environment, chosen based on participant preferences, to ensure they could freely share their experiences. The interviews were conducted by the principal investigator, a reproductive health professional with training in qualitative research methods and prior experience in oncology-related research. The interviewer also received additional training in conducting in-depth interviews and maintained a neutral and non-judgmental approach throughout the data collection process. Given the interviewer’s professional interest in cancer care, reflexive field notes and regular discussions with the research team were employed throughout the study to minimize potential bias and enhance the rigor and credibility of the analysis. Each interview lasted 35–45 min and was audio-recorded with the participant’s consent. Three interviews were conducted each day to allow integration of emerging issues into subsequent interviews. Data collection and analysis occurred concurrently until thematic saturation was reached, with no new themes emerging. Additionally, data collection was stopped when three consecutive interviews produced similar responses without new information. Data collection was then concluded once data redundancy was confirmed. Trustworthiness To ensure the trustworthiness of the study, key strategies were employed to enhance credibility, dependability, confirmability, and transferability. Credibility was achieved by using semi-structured, open-ended questions, allowing participants to freely express their experiences. Interviews were conducted in a private, comfortable setting, and data saturation was reached after 18 interviews, confirming comprehensive representation of participants’ experiences. Adapting the EORTC QLQ-C30 tool to the local context further ensured the findings’ relevance. Dependability was ensured through a standardized data collection procedure, including a one-day training session for data collectors and strict adherence to a detailed interview guide. Confirmability was enhanced through transparent documentation of the research process, with all interviews audio-recorded, transcribed verbatim, and checked for accuracy. Member checking and peer debriefing were used to reduce bias and strengthen objectivity; Participants were invited to review summaries of their responses to ensure accuracy and completeness, and where applicable, their feedback was incorporated into the analysis to enhance the credibility of the findings. Transferability was supported by providing a thick description of the study context, participant selection, and data collection procedures, enabling readers to assess the applicability of the findings to other settings. These strategies collectively strengthened the rigor and trustworthiness of the study. Data analysis Data were analyzed using a thematic analysis approach guided by pre-established themes derived from a review of existing literature on health-related quality of life. These themes provided the initial framework for coding and thematic categorization. All audio-recorded in-depth interviews (IDIs) were transcribed verbatim and thoroughly reviewed multiple times. Field notes from the research assistant were incorporated to contextualize participant responses. Transcripts, originally in Tigrigna, were translated into English by the investigators. A second fluent translator reviewed all translations for accuracy. In cases of discrepancy, the principal and co-investigators re-examined the audio recordings to reach consensus. The principal investigator then conducted a final quality check before analysis. Prior to coding, the principal investigators read each transcript to ensure familiarity with the content, focusing particularly on data relevant to the predetermined thematic categories. Transcripts were formatted in Microsoft Word and imported into Open Code software for structured analysis. Coding was conducted collaboratively by the investigators, using the predefined thematic framework to categorize responses. Any uncertainties or divergent interpretations were resolved through discussion and consensus. After coding, data were organized into thematic categories aligned with the initial analytical framework. Themes were then refined and illustrated with direct quotations from participants. The analysis followed six key steps:1 familiarization with the data2, generation of initial codes3, identification of potential themes4, review and refinement of themes5, definition and naming of final themes, and6 production of the report. Comparative analysis was conducted across transcripts to explore how participants’ perspectives aligned or diverged within each theme. The analysis emphasized the depth and variability of experiences related to health-related quality of life, with findings presented in narrative form, structured according to the predefined thematic domains. Ethical consideration This study was conducted in accordance with the principles of the declaration of Helsinki. Ethical clearance was obtained from Health research ethics review committee (HRERC) of Mekelle University, college of Health sciences with ethical registration code (ERC) of 1494/2020. Participation was voluntary and oral informed consent was obtained from each respondent after through explanation of the purpose, risk, justice, right to withdraw and benefit of the study. Participants were informed that all the data obtained from them were kept confidential and anonymous. Result Socio-demographic profile of participants A total of eighteen in-depth interviews were conducted with breast cancer patients who had been undergoing chemotherapy for at least six months at Ayder Comprehensive Specialized Hospital. The participants’ ages ranged from 26 to 62 years. Among them, 55.56% were urban residents, and 77.78% were married (Table 1). Table 1Socio-demographic profile of breast cancer patients receiving chemo-therapy in Ayder comprehensive specialized Hospital, Mekelle, Ethiopia.VariablesNumber (%)Age of respondents <=303(16.67) 31–406(33.33) 41–504(22.22) > 505(27.78)Residence Urban10(55.56) Rural8(44.44)Marital status Married14(77.78) Single3(16.67) Divorced1(5.56)Occupational status Government employed6(33.33) House wife9(50.00) Merchant1(5.56) Private employed1(5.56) Farmer1(5.56)Educational status No formal education9(50.00) Primary school level3(16.67) Secondary school level1(5.56) Diploma and above5(27.78) Socio-demographic profile of breast cancer patients receiving chemo-therapy in Ayder comprehensive specialized Hospital, Mekelle, Ethiopia. Themes and sub-themes Theme 1: emotional function Most patients described receiving a breast cancer diagnosis as a profoundly shocking experience. Influenced by what they had heard or read from others, many perceived breast cancer as a fatal illness. Consequently, being informed of their diagnosis triggered intense feelings of stress, shock, and despair, as they believed that cancer was incurable. “It was incredibly shocking. My mind was overwhelmed, and my body felt tense. I didn’t believe this disease had a cure, and I never expected to be alive until now. However, my husband was by my side, offering constant support. He encouraged me not to stress and promised to take me to the best possible healthcare facility. He told me that while my breast may or may not remain intact, I shouldn’t worry. He reassured me that I could be cured and provided me with tremendous moral support.” (48-year-old patient). The emotional well-being of participants was also influenced by what they saw and heard in their communities. One participant shared that she knew two breast cancer patients from her area who passed away while undergoing treatment. This deeply stressed her, as she feared she would share the same fate. “I was deeply alarmed and frightened. I had heard that breast cancer is fatal, but I never heard of anyone being cured through treatment. My husband is a healthcare worker, and when I saw two women from Hewane die of cancer, I became convinced that cancer has no cure. So, when the doctor told me I had cancer, I felt hopeless. I thought I was going to die.” (32-year-old patient). Most participants also revealed that after being diagnosed with breast cancer and sharing their status, their emotional state became unstable and often unpredictable. Many reported feeling easily irritated, stressed, and angry, frequently quarreling with family members and others over trivial matters. However, over time, they found ways to improve and regain emotional stability. “At this point, I have seen improvement. In the beginning, I was upset, irritable, and worried, but now, thanks to the support and information from my healthcare providers, and after coming to terms with my condition, I have improved.” (28-year-old patient). The majority of participants also mentioned that things improved after they visited the healthcare facility. Many reported that receiving appropriate information from their doctors and sharing experiences with other breast cancer patients provided them with significant emotional relief. “Since I came to this hospital, I have received tremendous moral support. When I was at home, I felt like I was the only one suffering, but here, I see many others facing similar challenges. I feel emotionally stable now, especially after seeing individuals who have physically improved after their treatment. I have hope that I, too, will be cured.” (38-year-old patient). These experiences correspond closely to the emotional functioning domain of the EORTC QLQ-C30. Theme 2: social function Participants described that they were no longer involved in church, Edir (a local financial service organization), or other social gatherings as they had been before. The burden of the disease and the medications they were taking made it difficult for them to engage in these activities. Additionally, many participants believed that the community looked down on them, which affected their relationships with friends, relatives, and neighbors. This theme closely reflects the social functioning domains of the EORTC QLQ-C30 framework. “The disease has a very serious impact. It makes me avoid being around people. I feel as though others dislike me, so I have withdrawn from my social life. However, the community and my family have been a great support to me.” (60-year-old patient). Many participants also shared that, after their diagnosis, they often had to travel long distances to different facilities for treatments such as surgery, chemotherapy, and radiotherapy. They felt helpless, as they were unable to care for their families or children, which led to increased stress and worry. Many believed that this emotional strain worsened their condition and contributed to their sense of misery. “When I went to Addis Ababa for radiotherapy, I faced many challenges. Being separated from my children and other family members because of this disease caused me a great deal of stress and frustration. I have a three-year-old child whom I had to leave behind at home. However, because I was so worried about her, I returned home before finishing my treatment and took her with me to Addis Ababa so she could stay with me until I completed my radiotherapy. This situation made my life very difficult and miserable.” (48-year-old patient). Many participants explained that while their parents and children were always by their side, providing support in various ways as needed, their husbands were often unsupportive and emotionally distant. When husbands realized the financial burden of the disease and the responsibility of caring for the children, they became argumentative and disagreed on many decisions. This tension sometimes led to marital breakdowns and family disintegration, which in turn worsened the patients’ conditions. Participants also shared that once their illness became apparent, many relatives distanced themselves and lacked a supportive attitude. “When my husband found out I had breast cancer, he left me and went to stay with his family. This caused a quarrel between my parents and his. Before I became ill, I lived in my own home, but after my husband left for his parents’ house and there was no one to care for my children, I had to move in with my parents. Now, it’s my mother who prepares food for us.” (26-year-old patient). “…My parents are already deceased, and there is no one supporting me now. When you’re sick, people aren’t as kind as you’d hope. The support from my relatives has been poor. Instead of helping, they irritate me, worry me, and act as though they are overly concerned. They don’t even greet me. I often wonder if they look down on me because I’m sick. Sometimes, I feel like leaving everything behind and going to a monastery, but I can’t because I have two children and a husband to take care of.” (37-year-old patient). Almost all patients shared that they did not have sufficient financial resources to cover their treatment and transportation costs. Upon being diagnosed with breast cancer, they were required to pay for surgery, chemotherapy, and radiotherapy at the healthcare facilities. Furthermore, since these services were spread across different health centers located far from one another, many patients expressed frustration over the high costs of transportation and accommodation. In order to meet these financial demands, patients were forced to sell livestock and other household possessions, as well as borrow money from friends, relatives, and neighbor an especially difficult task in a setting with limited resources. “Before I was certified and became eligible for free insurance services, I paid twenty thousand birr for the operation. Prior to that, I also had two laboratory investigations and two ultrasound exams, for which I paid three thousand birr. I lost everything my cow, ox, and donkey just to cover the cost of my medical care.” (50-year-old patient). “My children and husband were very worried. At the beginning, I didn’t have medical insurance, and as a result, I faced a lot of difficulties. I had to borrow money to cover my medical expenses.” (62-year-old patient). Theme 3: cognitive function Most participants reported that their cognitive functioning remained largely unaffected despite the emotional and physical challenges associated with their illness. They indicated that they were generally able to concentrate, remember information, and engage in routine mental activities without difficulty. Activities such as reading newspapers, watching television, and planning or completing daily tasks were carried out with normal attention and focus. Although participants acknowledged experiencing stress, anxiety, and emotional distress related to their condition, these feelings did not appear to significantly interfere with their ability to think clearly or maintain concentration. “I don’t have any issues with concentration. I have no trouble watching television or reading newspapers. In fact, these activities entertain me and give me hope during this difficult time.” (34-year-old patient). Similarly, others explained that remaining mentally engaged in everyday activities helped maintain a sense of control and independence despite the stress associated with the illness. Participants emphasized that keeping their minds occupied reduced excessive worry and enabled them to continue participating in family and social discussions. Theme 4: physical function of participants Performance in heavy and light duty works Most of the study participants reported that, since being diagnosed with breast cancer, they were unable to perform strenuous activities that required significant physical effort, such as lifting heavy items. They explained that the pain and weakness they experienced left them unable to engage in or successfully complete such demanding tasks. These experiences correspond closely to the physical and role functioning domains, as well as the pain and fatigue symptom domains, of the EORTC QLQ-C30 framework. “Since being diagnosed with breast cancer, I have been completely unable to engage in heavy-duty work. Even when I try to do very light tasks, I suffer greatly because the skin on my chest feels stretched in all directions.” (34-year-old patient). Many participants reported that their ability to perform daily tasks further declined after undergoing surgery, leading to the majority of household chores being taken over by their family members or relatives. “I try to do my work at home, but I am limited on the side where the surgery was performed. It feels tight there, and sometimes it swells, bursts, and releases blood. The tightness in my chest also restricts the movement of my arm. Because of this, my energy continues to decline over time.” (54-year-old patient). However, nearly all of the participants reported that, aside from the pain they experienced on the affected side while dressing, they had no difficulty independently performing simple activities such as dressing, eating, and using the toilet. “When I wash and apply pressure to the affected side while wearing tight clothes, I feel pain. However, I have no trouble eating or using the toilet on my own. Of course, when I’m undergoing chemotherapy, there are times when I am unable to do any tasks, and my family helps me with preparing food and washing clothes.” (28-year-old patient). Limitation in walking long and short distances Most participants reported lacking the strength to take long walks. However, when they occasionally attempted to walk longer distances, they felt extremely weak and experienced pain, particularly around the affected side and the area where the surgery was performed. As a result, they described themselves as unable to successfully complete long walks. “When I walk, I experience significant limitations, even in the pace of my movement. When I stand, I feel pain in my joints. I don’t often go on long journeys, but when I do, I feel weak, and every part of my body aches.” (48-year-old patient). Additionally, many participants reported feeling weak after walking even short distances. They mentioned that while the pain and weakness might not be immediately noticeable or problematic during the walk itself, once they returned home, they experienced discomfort that disrupted their sleep patterns at night. “When I rest, I feel better. However, when I move, engage in a task, or walk even a short distance, I experience pain and discomfort that affects my sleep at night. From this, I understand that this disease requires rest.” (60-year-old patient). Common places where patients spend most of their time The majority of participants reported that before starting chemotherapy, they spent most of their time at home, preparing meals for their families and managing other household tasks. However, after beginning chemotherapy, they described themselves as feeling weak and spending the majority of their time confined to bed or sitting in a chair, watching television at home. They noted that they were no longer able to go for even short walks outside their home. “Since I started treatment, I spend all my time at home. During the day, I either lie in bed or sit in a chair. I don’t go outside except to visit the hospital for medical care, like I’m doing today.” (45-year-old patient). Theme 5: symptoms Most participants shared that from the moment they suspected they had the disease, they often experienced moderate to severe pain. Initially, the pain was localized to the area of the breast where the lump was detected. However, for many patients, as the disease progressed and surgery was performed, the pain spread to the surrounding tissues, becoming more intense. This pain significantly impacted their daily activities and the range of motion in their body parts. In addition to the physical discomfort, participants noted that the pain also affected their mood, making it difficult for them to sleep at night. Other symptoms, such as a burning sensation, vomiting, weakness, severe breast pain, sweating, and a loss of movement, were also reported by the participants. These experiences align with the pain, physical functioning, fatigue, insomnia, and emotional functioning domains of the EORTC QLQ-C30 framework. “After being diagnosed with breast cancer, I experienced severe pain in my breast and felt extreme weakness in my body. In addition, I suffered from intermittent sweating and a burning sensation throughout my body, including my shoulder. I also have significant limitations in movement in the area where the operation was performed.” (62-year-old patient). Participants reported that before starting chemotherapy and immediately after treatment began, they experienced intermittent constipation, diarrhea, loss of appetite, and sleep disturbances. However, after a period of time, these symptoms subsided, and patients indicated that they began to feel better. “After starting treatment, my bowel habits improved. I occasionally experienced constipation, but it was only for one day. Previously, I had a significant loss of appetite and wasn’t interested in any food. However, now that I’ve begun treatment, I can eat any type of food.” (54-year-old patient). Theme 6: drug side effects experienced after treatment initiation The majority of patients reported hair loss along with fatigue, body aches, nausea, and reduced appetite after beginning chemotherapy. Through thorough pre-treatment counseling, participants felt mentally prepared and were not significantly alarmed. Menstrual irregularities and abdominal discomfort were also frequently reported during the treatment period. However, over time, many participants noted that these symptoms became less intense and more manageable. These experiences correspond closely to the symptom burden, physical functioning, and, to some extent, emotional functioning domains of the EORTC QLQ-C30 framework. “Oh, the medication is very strong. During treatment, the food smells awful and unappetizing. By the second month of my treatment, I lost all my hair, but since I was informed about the side effects beforehand, I wasn’t psychologically affected. Additionally, chemotherapy disrupts your sleep; it keeps you awake, causing vomiting and pain. You just feel unwell. It also gives you a burning sensation, almost like a fever.” (48-year-old patient). Participants also noted that body hair loss varied across different phases of treatment. They reported that while all body hair was lost during the first and third phases, it began to regenerate during the second phase of treatment. “In the first phase of treatment, all of my scalp hair fell out. However, when I started taking the tablets, it began to regenerate. Unfortunately, when I began the third phase of treatment, my hair fell out again.” (54-year-old patient). Discussion Understanding the quality of life of chronic patients undergoing surgical and other therapeutic treatments is crucial for developing effective palliative care services and coping strategies. This qualitative study aimed to explore the quality of life of breast cancer patients receiving chemotherapy at Ayder Comprehensive Specialized Hospital in Tigray. It focused on participants’ experiences with physical, cognitive, emotional, and social functions, as well as symptoms and treatment side effects. The findings are intended to help improve palliative care and coping strategies for these patients. The study found that most patients were no longer able to perform strenuous activities they had managed before their diagnosis. This decline in physical function worsened following surgery and the start of chemotherapy. This aligns with existing literatures reporting that while cancer treatment often reduces overall physical functioning, many patients retain the ability to manage basic activities of daily living (ADLs)27–30. Exhaustion and difficulty with heavy tasks were linked to the combined effects of chemotherapy, the disease, and surgical or tumor site pain. Additionally, pain and weakness from both the disease and chemotherapy were significant factors limiting patients’ ability to walk short and long distances31. Unlike other previous study32, participants in this study exhibited intact cognitive function. Despite the stress from medications and the disease process, they did not face difficulties with concentration. The differences in cognitive function may be attributed to several factors. Variations in sample characteristics, such as age and cancer stage, could influence cognitive outcomes. The participants in this study may have had a less aggressive treatment regimen or experienced a different disease progression, which could have helped preserve cognitive function. The timing of cognitive assessments might have also affected the results, as they could have been conducted during a recovery phase with fewer cognitive impairments. Additionally, individual factors such as resilience, coping strategies, and overall health may have contributed to their ability to maintain focus and perform daily activities effectively. The emotional wellbeing of participants was profoundly affected upon learning of their diagnosis. When informed that they had breast cancer, nearly all patients experienced shock. However, the emotional wellbeing of most participants improved significantly after receiving counseling. These findings are consistent with those of similar studies33–39. The patients’ initial emotional reactions, such as shock, fear, and hopelessness, can be explained by the overwhelming nature of a cancer diagnosis, which is often associated with life-threatening implications. Many patients, having heard cancer is typically fatal, naturally fear for their lives upon diagnosis. This fear, combined with uncertainty about the future, triggers heightened stress and emotional instability. The psychological burden of facing such a significant health crisis, coupled with societal perceptions of cancer, often results in irritability, stress, and interpersonal conflicts, especially with family members who may not fully understand the emotional complexities involved. However, the improvement in emotional wellbeing observed after counseling and peer support can be attributed to effective coping mechanisms and the role of social support. Counseling offers patients clarity, helping them process their emotions and gain a better understanding of their diagnosis, which reduces uncertainty. Peer support, where patients share experiences with others facing similar challenges, fosters a sense of community, helping to reduce feelings of isolation. The exhaustion resulting from the disease burden, treatment side effects, and severe pain, together with negative societal attitudes toward breast cancer, significantly impaired participants’ social functioning. These findings are consistent with evidence from a systematic review40. This can be attributed to the fact that many participants were unable to engage in usual social activities, such as attending church, due to the effects of the disease and its treatment, and were required to travel long distances for care, resulting in prolonged separation from their families. Almost all patients reported lacking sufficient financial resources to cover their treatment and transportation costs. Furthermore, as these services were spread across multiple health facilities located far apart, they faced significant expenses for transportation and accommodation. This finding contrasts with studies conducted in Sweden, Brazil, and Iran41–43, where patients may have had more access to financial support or resources. The variation in financial strain experienced by patients in this study compared to those in Sweden, Brazil, and Iran can be explained by differences in healthcare systems and social safety nets. In many countries, such as Sweden, Brazil, and Iran, public healthcare systems or government programs may provide greater financial support for cancer treatment, reducing the financial burden on patients. In contrast, the lack of comprehensive healthcare coverage or financial assistance in the setting of this study leaves patients with limited resources, forcing them to sell assets and borrow money to cover treatment and transportation costs. Consistent with other studies27,29,31,36, most patients reported severe breast pain, weakness, burning sensations, limited movement, intermittent constipation, loss of appetite, and sleep disturbances. After treatment began, all symptoms, except for pain and weakness, improved. Additionally, weakness, hair loss, menstrual disturbances, and loss of appetite were noted as side effects of chemotherapy, aligning with findings from other studies32,44,45. The pain and symptoms reported by patients are primarily due to the physical impact of breast cancer and the trauma caused by surgery, affecting surrounding tissues. Chemotherapy side effects, such as weakness, hair loss, and loss of appetite, result from the treatment’s effect on both cancerous and healthy cells. While many symptoms improve over time as the body adjusts to treatment, persistent pain and weakness often remain due to the lasting effects of both the disease and its treatments. The qualitative themes identified in this study demonstrated substantial alignment with the conceptual domains of the EORTC QLQ-C30. Themes related to fatigue, pain, and reduced daily activity reflected the physical functioning and symptom burden dimensions, while participants’ accounts of distress, fear, and uncertainty aligned with emotional functioning. Similarly, descriptions of reduced social participation and dependency on family members corresponded to the social functioning domain. This convergence suggests that the QLQ-C30 framework adequately captures many aspects of patients’ lived experiences within the present context, while the qualitative findings also provide deeper contextual understanding of how these challenges are experienced and interpreted by participants. Limitation of the study This study has several limitations that should be considered when interpreting the findings. First, the study was conducted at the only hospital in the region providing cancer treatment services, which may limit the transferability of the findings to other settings. Second, although a simple random sampling technique was employed, the possibility of selection bias cannot be entirely excluded. In addition, data were collected in 2020 during the COVID-19 and the onset of war in the Tigray Region, both of which may have influenced participants’ psychological well-being, access to healthcare services, and overall experiences. Therefore, the findings should be interpreted within the context of these circumstances. Furthermore, patients who discontinued chemotherapy early were not included, which may have resulted in the omission of important perspectives on treatment experiences. Participation was also limited to those who were willing to take part in the interviews, which may have excluded the views of individuals who declined participation. In addition, the study relied on self-reported data, which may be subject to recall bias and variation in participants’ perceptions and experiences. Despite these limitations, the study provides valuable insights into the experiences and side effects of chemotherapy among patients in the study setting. Conclusion This study highlights the significant impact of chemotherapy on the health-related quality of life (HRQoL) for breast cancer patients, particularly affecting their physical, emotional, and social well-being. Patients often face physical limitations, such as difficulty walking or performing daily tasks, alongside emotional distress like fear and uncertainty about their prognosis. The dual burden of cancer and treatment, combined with insufficient social support, leads to heightened anxiety and emotional turmoil. However, those who received emotional support from healthcare providers and peer networks showed improved emotional stability and coping mechanisms. The study recommends that healthcare providers offer more comprehensive support systems, which should include not only medical care but also emotional counseling, psychological assistance, and community engagement. Peer support groups are critical for patients to share experiences and encourage one another. Additionally, policymakers should focus on improving healthcare access, reducing financial burdens, and expanding insurance coverage. It is also essential to create national guidelines integrating mental health and social welfare services into cancer treatment. Future research should explore the long-term psychological and financial effects of chemotherapy to guide the development of better patient care strategies and policies for a holistic approach to patient support. Acknowledgements We would like to extend our gratitude to all health professionals working in Ayder comprehensive specialized Hospital data collection sites for their cooperation during data collection. Further, we are grateful to the study participants and data collectors for providing us valuable information and undertaking their tasks with extreme caution respectively. Author contributions D.H.: Conceived and designed the study, supervised the data collection, performed the analysis, interpretation of data, and drafted the article. H.B., H.B.K., G.B., K.K., Y.B.: Participated in Co-designing the study, data interpretation, supervised the data collection, data analysis and they critically reviewed the article. S.A.: Assisted in data interpretation, data collection and critically reviewed the article. All authors have read and approved the final article. Funding This study was conducted with the financial support of Mekelle University. Author(s) received no financial support for authorship, and/or publication of this article. Data availability The raw data file could be provided for research purpose up on request via email of the corresponding author (mailto: destahailu19@gmail.com). Declarations Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Desta Hailu Aregawi, Haftu Berhe Gebru, Hailemariam Berhe Kahsay, Gerezgiher Buruh Abera, Kalayu Kidanu Berhe, Yibrah Berhe and Senait Abrha contributed equally to this work. References Associated Data Data Availability Statement The raw data file could be provided for research purpose up on request via email of the corresponding author (mailto: destahailu19@gmail.com).